Bruker Corp BRKR Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$61.31 up $3.25, 5.60% at close Nov 6
Last close · Previous close $58.06
- Market cap
- $9.34BAt the Nov 6 close
- P/E ratio
- n/mLoss over last 12 months
- Diluted EPS
- −$1.10Last 12 months
- Dividend yield
- 0.33%Last 12 months
Price chart
$61.31up $3.25, 5.60%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$58.06Nov 5
- Volume2.01MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.49MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $32.37 to $68.98; now $61.31
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
BRKR beat the S&P 500 in 4 of 7 periods.
| Period | BRKR and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BRKR: up 1.3% S&P 500: down 5.6% | BRKR beat the S&P 500 by 6.9 percentage points Beat |
| 3M | BRKR: up 19.7% S&P 500: down 4.1% | BRKR beat the S&P 500 by 23.8 percentage points Beat |
| YTD | BRKR: up 30.6% S&P 500: up 8.7% | BRKR beat the S&P 500 by 21.9 percentage points Beat |
| 1Y | BRKR: up 56.6% S&P 500: up 10.9% | BRKR beat the S&P 500 by 45.7 percentage points Beat |
| Long term | ||
| 3Y | BRKR: up 10.5% S&P 500: up 75.0% +3.4% vs +20.5% a year | BRKR trailed the S&P 500 by 64.5 percentage points Trailed |
| 5Y | BRKR: down 23.6% S&P 500: up 67.8% −5.2% vs +10.9% a year | BRKR trailed the S&P 500 by 91.4 percentage points Trailed |
| 10Y | BRKR: up 189.6% S&P 500: up 313.1% +11.2% vs +15.2% a year | BRKR trailed the S&P 500 by 123.5 percentage points Trailed |
$10,000 invested in BRKR 10 years ago (Nov 4, 2016) would be worth about $28,964 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,313.
BRKR beat the S&P 500 in 4 of 7 periods.
| Period | BRKR and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BRKR: up 1.3% S&P 500: down 5.6% | BRKR beat the S&P 500 by 6.9 percentage points Beat |
| 3M | BRKR: up 19.6% S&P 500: down 4.3% | BRKR beat the S&P 500 by 23.9 percentage points Beat |
| YTD | BRKR: up 30.1% S&P 500: up 7.8% | BRKR beat the S&P 500 by 22.3 percentage points Beat |
| 1Y | BRKR: up 56.0% S&P 500: up 9.7% | BRKR beat the S&P 500 by 46.3 percentage points Beat |
| Long term | ||
| 3Y | BRKR: up 9.2% S&P 500: up 68.8% +3.0% vs +19.1% a year | BRKR trailed the S&P 500 by 59.6 percentage points Trailed |
| 5Y | BRKR: down 24.9% S&P 500: up 56.9% −5.6% vs +9.4% a year | BRKR trailed the S&P 500 by 81.8 percentage points Trailed |
| 10Y | BRKR: up 178.6% S&P 500: up 252.6% +10.8% vs +13.4% a year | BRKR trailed the S&P 500 by 74.0 percentage points Trailed |
$10,000 invested in BRKR 10 years ago (Nov 4, 2016) would be worth about $27,856 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,257.
All-time high
$94.27
Closing high on . Now 35.0% below that record.
Split-adjusted daily closes since Aug 4, 2000.
Stock splits
BRKR hasn’t split since its price history begins in 2000.
Valuation
The Nov 6 close compared with the last 12 months of reported results (the four quarters to Sep 30, 2026). Tap a metric to see how it’s calculated.
Price-to-earnings (P/E)
n/mDiluted EPS of −$1.10 over the last 12 months
A P/E ratio isn’t meaningful while earnings over the last 12 months are negative. When BRKR was profitable over the past five years, its P/E ranged from 21.8× to 84.4×, with a median of 33.9×. How to read P/E
Other valuation measures
- 2.7×Last 12 months’ revenue
Market value divided by revenue over the last 12 months. Useful when earnings are small or negative.
P/S = Market cap ÷ Revenue (last 12 months)Price-to-sales ratio - 4.1×Book value as of Sep 30, 2026
Price relative to accounting equity (book value) per share on the Sep 30, 2026 balance sheet. Asset-light companies often trade far above book value.
P/B = Price ÷ Book value per sharePrice-to-book ratio - 70.3×Last 12 months’ EBITDA
Enterprise value divided by EBITDA over the last 12 months. It compares companies with different amounts of debt.
EV/EBITDA = Enterprise value ÷ EBITDA (last 12 months)EV/EBITDA explained - 2.62%Last 12 months’ free cash flow
Free cash flow over the last 12 months as a share of the company’s market value: the cash the business generated for each dollar of stock.
FCF yield = Free cash flow (last 12 months) ÷ Market capFree cash flow - $10.93BAt the Nov 6 close
What it would cost to buy the whole business: the market cap at the Nov 6 close, plus debt, minus cash and short-term investments from the Sep 30, 2026 balance sheet.
EV = Market cap + Debt − Cash and short-term investmentsEV/EBITDA explained
Build your own BRKR DCF in Excel. Value Bruker with your own growth and margin assumptions.Browse DCF models Free DCF calculator
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q3 FY26, the quarter ended Sep 30, 2026. “Last 12 months” means the four quarters from Oct 1, 2025 to Sep 30, 2026, and balance-sheet figures are as of Sep 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $3.51Bup 2.2%
- Net income
- −$123.40M
- Diluted EPS
- −$1.10
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY24 (Dec 31, 2024) | $979.60M | $13.70M | $0.09 |
| Q1 FY25 (Mar 31, 2025) | $801.40M | $17.40M | $0.11 |
| Q2 FY25 (Jun 30, 2025) | $797.40M | $7.60M | $0.05 |
| Q3 FY25 (Sep 30, 2025) | $860.50M | −$59.60M | −$0.41 |
| Q4 FY25 (Dec 31, 2025) | $977.20M | $26.00M | $0.10 |
| Q1 FY26 (Mar 31, 2026) | $823.40M | $14.40M | $0.02 |
| Q2 FY26 (Jun 30, 2026) | $838.50M | −$52.00M | −$0.41 |
| Q3 FY26 (Sep 30, 2026) | $874.00M | −$111.80M | −$0.81 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY21 (Dec 31, 2021) | $2.42B | $277.10M | $1.81 |
| FY22 (Dec 31, 2022) | $2.53B | $296.60M | $1.99 |
| FY23 (Dec 31, 2023) | $2.96B | $427.20M | $2.90 |
| FY24 (Dec 31, 2024) | $3.37B | $113.10M | $0.76 |
| FY25 (Dec 31, 2025) | $3.44B | −$8.60M | −$0.15 |
Margins
- Gross 47.7%
- Operating −2.0%
- Net −3.5%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $244.70MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$341.80MLast 12 months
- Capital spending$97.10MLast 12 months
- 7.0%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $3.80MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$30.30MLast 12 months
- Total returned$30.30MLast 12 months
12% of free cash flow
Balance sheet
- $119.70MAs of Sep 30, 2026
Cash plus short- and long-term marketable securities on the Sep 30, 2026 balance sheet.
- Total debt$1.71BAs of Sep 30, 2026
- Net debt$1.59BAs of Sep 30, 2026
- 1.84As of Sep 30, 2026
Current assets divided by current liabilities on the Sep 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.74As of Sep 30, 2026
Total debt divided by shareholders’ equity on the Sep 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 4 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✗Net income was positive: not passed
- ✓Operating cash flow was positive: passed
- ✗Return on assets improved: not passed
- ✓Operating cash flow exceeded net income: passed
- ✓Long-term debt fell relative to assets: passed
- ✗Current ratio improved: not passed
- ✗Share count didn’t rise: not passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- −5.1%Last 12 months
Over the last 12 months, Bruker lost money: its net loss was 5.1% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - −2.0%Last 12 months
Over the last 12 months, Bruker’s net loss was 2.0% of its total assets (averaged over the last four quarter-ends).
ROA = Net income (last 12 months) ÷ Average total assets
Dividends
Cash dividends per share by ex-dividend year, adjusted for splits.
Dividends per share
Data table
| Year | Per share |
|---|---|
| 2016 | $0.16 |
| 2017 | $0.16 |
| 2018 | $0.16 |
| 2019 | $0.16 |
| 2020 | $0.16 |
| 2021 | $0.16 |
| 2022 | $0.20 |
| 2023 | $0.20 |
| 2024 | $0.20 |
| 2025 | $0.20 |
| 2026 (to date) | $0.15 |
Dividend details
- $0.20Per share, last 12 months
Cash dividends per share with ex-dividend dates in the last 12 months.
- 0.33%; 5-yr low 0.19%, 5-yr high 0.68%Last 12 months
Dividends paid over the last 12 months as a share of the Nov 6 close. The bar shows where that yield sits in its range over the past five years; the median was 0.31%.
- $0.050Ex-dividend
The most recent payment per share. Shares bought on or after the ex-dividend date don’t receive it.
- FrequencyQuarterly4 payments in the last 12 months
- up 4.6% a yearFull years 2020–2025
The compound annual growth rate of the full-year dividend per share from 2020 to 2025.
About Bruker Corp
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Massachusetts, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
BRKR news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BRKR stock FAQ
What is BRKR stock’s price today?
Bruker (BRKR) traded at $61.31 at the close on , up $3.25 (5.60%) from the previous close of $58.06. Over the past 52 weeks it has traded between $32.37 and $68.98.
If you invested $1,000 in BRKR 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in BRKR on would be worth about $2,896 at the close on , a total return of +189.6%. The same $1,000 would be worth $764 if invested five years ago, $1,566 if invested one year ago, and $8,201 if invested 20 years ago. Past performance doesn’t predict future returns.
What is Bruker’s market cap?
Bruker’s market capitalization is about $9.3 billion. That’s Tiingo’s daily market cap for , at that day’s closing price of $61.31 (how market cap works). Bruker reported 152.36M shares outstanding at the end of its latest quarter ().
What is BRKR’s P/E ratio?
BRKR’s P/E ratio isn’t meaningful right now because its earnings over the four quarters to are negative (diluted EPS of −$1.10). When it was profitable over the past five years, its P/E ranged from 21.8 to 84.4.
How much revenue does Bruker make?
Bruker reported $3.5 billion of revenue over the four quarters to , up 2.2% from the twelve months before. In its latest quarter (Q3 FY26, ended ) revenue was $874.0 million, up 1.6% from a year earlier.
Is Bruker profitable?
Not over the four quarters to . Bruker reported a net loss of $123.4 million across those four quarters on $3.5 billion of revenue.
What are BRKR’s earnings per share?
BRKR’s diluted earnings per share were −$1.10 over the four quarters to , compared with −$0.16 in the twelve months before. The latest quarter (Q3 FY26) brought −$0.81 per share, against −$0.41 a year earlier (how EPS works).
Does BRKR pay a dividend?
Yes. Bruker pays a quarterly dividend. The most recent was $0.050 per share, with an ex-dividend date of . Over the last twelve months it paid $0.20 per share, a 0.33% yield at the close (how dividend yield works).
Based on the last 12 months’ payments ($0.20 per share), and if the next 12 months match the last 12, 100 shares would receive about $20 over 12 months, and $1,000 over 12 months would take about 5,000 shares, roughly $306,550 at the close. Dividends can change.
What is BRKR’s 52-week high and low?
Over the past 52 weeks BRKR has traded as low as $32.37 and as high as $68.98. At $61.31 at the close on , it is 11.1% below that high and 89.4% above the low.
What is BRKR’s all-time high?
BRKR’s highest closing price was $94.27 on , adjusted for stock splits. At $61.31 at the close on , it is 35.0% below that record.
Has BRKR stock ever split?
No. BRKR hasn’t split since its price history begins in 2000.
How has BRKR stock performed?
Including dividends and measured to the close on , BRKR has returned +30.6% so far this year and +56.6% over the past year, and −23.6% over five years (−5.2% a year). Over the same periods the S&P 500, measured by SPY, returned +8.7%, +10.9% and +67.8%. Past performance doesn’t predict future returns.
What sector and industry is Bruker in?
Bruker is in the Healthcare sector and the Medical Devices industry, and is headquartered in Massachusetts, USA.
What exchange does BRKR trade on?
Bruker trades on the Nasdaq under the ticker symbol BRKR. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.